Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
about
Atherosclerosis and infection: is the jury still not in?Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsThe clinics of acute coronary syndromeWhat happens to cardiovascular system behind the undetectable level of HIV viremia?Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusMetabolic syndrome, diabetes, and cardiovascular risk in HIVThe role of oxidative stress and inflammation in cardiovascular agingMenopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implicationsAssociation of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisAcute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapyHIV infection and cardiovascular diseaseDiagnosing and managing diabetes in HIV-infected patients: current conceptsHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesHIV and aging: emerging research issuesMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsArterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?The role of statins in the setting of HIV infectionIdentifying the appropriate comparison group for HIV-infected individualsHIV infection and the risk of acute myocardial infarction.Untangling the Gordian knot of HIV, stress, and cognitive impairmentRole of high-sensitivity C-reactive protein measurements in HIV patientsA Review of Management of Inflammation in the HIV PopulationFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVIncreased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and TatManaging dyslipidemia in HIV/AIDS patients: challenges and solutionsCardiovascular Complications of HIV-Associated Immune DysfunctionA cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in ZimbabweThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionSevere morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortFactors associated with tobacco smoking and cessation among HIV-infected individuals under care in Rio de Janeiro, BrazilA randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individualsMyocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitorsHypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional studyAgeing and inflammation in patients with HIV infection.Cardiovascular Complications of HIV in Endemic Countries.Cardiovascular Disease, Statins, and HIVAtherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individualsRisk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography.
P2860
Q22241306-69E6C8BD-5190-4687-8C64-28447973124BQ26740117-179E9FCC-7AE8-43DE-8173-CCE311AC9AD6Q26746739-48641D49-8C08-47CB-9308-FE700E1FE6D7Q26749024-C7012714-1D4C-4680-B726-81BFB706D1E9Q26777866-B4672EE3-496B-4755-8216-FB092BA569C3Q26851535-4C245D48-0737-4604-9ED0-1FF8347565ADQ26853470-7BB08FD3-825C-46B7-B673-A213C49E3162Q26864987-611C3C26-1C42-4813-87E5-4C2074BEA9B3Q26865187-22C19999-72F5-4A61-BC13-E4C750C9879FQ27000959-8581DE00-66A4-4F33-ADA1-A0F9822B7759Q27008328-85C2A485-BD16-42B2-94F8-2E5A0F6688EAQ27008915-73E6E707-6FAB-4291-9261-DF63D52F6925Q27014697-BE1EC39C-B8F3-4702-A822-31AAEB36FE74Q27015965-F9DF00D8-7A17-4B14-A41C-FEB00DE3C4E7Q27016011-6E53FD39-1E54-4321-9840-F397C30A64CCQ27024262-AD8E588D-5535-4760-9892-7E380491DF86Q27026486-D17F668E-050F-429F-9DDD-A29A947DA5DAQ27027724-573EF6BD-9E4B-43C8-84B8-C2317A4AD364Q27028033-93E6EA27-91FD-44B1-8C0D-14BEB185E531Q27347231-FBAA7AF8-FF13-48B5-9C11-744EF1F98794Q28067483-7CEC3A65-ED8B-4208-89A7-D411B75D0DDEQ28067891-AF33BE4A-7297-4915-8FA8-B629D0D67E91Q28078962-B88EB198-B574-4886-8B2D-4F118A97A682Q28079826-6B15BDB8-1D34-43C6-BFDB-4DDC6DAF472AQ28080948-E589B72D-5F91-4FC8-9391-FB31EEF3FEACQ28084941-AFDDF09E-467B-4B9D-8285-3E62724F7724Q28084981-F7FC723C-8CCF-46C8-9F75-3F848572E351Q28385694-8953BD8C-3794-434B-846E-E0724EB0EFA7Q28386344-A83EB998-6FB9-43D0-BADD-75FE3ACE9A22Q28541356-6081320B-67A7-4546-8E5F-D01075453367Q28542839-5839E5EA-A304-4C50-9A93-DBAA8793FF9EQ28543212-CC8F51F1-8E92-4EA3-9542-BA042CE626EAQ28743987-2D3A532D-DCFC-41F6-B134-8A67B39E5C48Q28744647-820F289F-24FC-4AC7-88F0-F48EBF1E028AQ30244296-73158821-1448-40DD-8E50-4BED79FDEA85Q30244655-877617D4-F403-446C-A443-68E37400CBC9Q30245373-C05F130A-A9F8-45F4-8BB9-E24E549E0908Q30248286-5E4C288D-3E72-4175-A1C7-C83A60C7A446Q30366554-40432014-FD88-4089-8D1C-84EEA30AFAFFQ30457521-D8A71A7A-2886-42FA-A04E-E0E7A675C0F0
P2860
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased acute myocardial inf ...... immunodeficiency virus disease
@en
Increased acute myocardial inf ...... mmunodeficiency virus disease.
@nl
type
label
Increased acute myocardial inf ...... immunodeficiency virus disease
@en
Increased acute myocardial inf ...... mmunodeficiency virus disease.
@nl
prefLabel
Increased acute myocardial inf ...... immunodeficiency virus disease
@en
Increased acute myocardial inf ...... mmunodeficiency virus disease.
@nl
P2093
P2860
P921
P356
P1476
Increased acute myocardial inf ...... immunodeficiency virus disease
@en
P2093
Colleen Hadigan
Steven K Grinspoon
Virginia A Triant
P2860
P304
P356
10.1210/JC.2006-2190
P407
P577
2007-04-24T00:00:00Z